For what it is worth? This was e-mailed to me.
New Technology
KILLS CANCER CELLS.
A revolution in cancer treatment.
Buy PYTO today for potential gains of 500% in 90 days.
Fellow Investor
This could be the discovery that changes everything in the way cancer is treated.
PhytoMedical Technologies (PYTO) just announced that the developmental drug they’ve been working on has now been proven to kill brain cancer cells.
What’s more, it works in a novel new way that could potentially be an entirely new class of class of drug that has only been dreamed of before.
And that could translate to millions in profits for early investors.
Science has searched for the holy grail of cancer treatment for 60 years, but till now every method to treat cancer at the molecular level has failed at one critical point – the ability of the drugs to bind firmly to the diseased DNA.
Investors flock to any sign that a new medical innovation may be moving toward commercialization, and cancer stocks often move highest.
And now this historic news from PhytoMedical Technologies (PYTO) could rocket the stock to huge gains.
Now, I expect PYTO to surge 500% or more in 90 days.
Here’s why….
Buy on news, hold on for fast gains.
When you get in early, just at the point of positive news, you can pocket riches on cancer-related stocks.
One pharmaceutical stock shot up 280% in the first 14 days of December after announcing that one of their technologies showed positive results.
Just a few months ago, in July 2007, one tiny cancer research company with a $7 million market cap nearly tripled after its progress was profiled in two leading biotech publications.
A month before that another shot up 176% in less than a month, from $1.26 to $3.48, on positive results of its preclinical studies.
And earlier in the year, yet another cancer-related stock scored 65% gains in 23 days just on news of a different cancer-related stock!
And after announcing positive clinical results for its own cancer drug, the stock nearly doubled.
Another rocketed 120% in the last five and a half months of 2007 – and 5,320% in the last five years.
The secret to gains like these is to get in at the right time.
And NOW is the right time for PYTO – I’m projecting a potential for 500% or more in 90 days because of the current low price of the stock and the importance of their research.
For details on PYTO’s cancer research, including the exciting new developments that could mean the first new class of cancer drug in 50 years, pushing huge stock gains today, you can see them here.
I strongly suggest that you consider investing in PYTO today.
Sincerely,
Ken Coleman
Publisher, The Investment Tracker
Ken Coleman's Investment Tracker subscribers are up 66.79% per year average over the past 4 years. He is a former member of the Senate Select Committee on Federal Reserve Policy, and his show is syndicated nationally on TNN.
View Report
AI
